Background: Airway epithelial cell (AEC) function differs between children with and
understanding of the early origins of asthma may lead to novel interventions which palliate and cure symptoms.
Bias in the differentiation of the cellular immune system, where T-helper type 2 (Th2) lymphocytes predominated over Th1, was traditionally thought to be the critical process in the development of asthma. 7 More recently the primacy of the cellular immune system in the development of asthma has been questioned 8 and airway epithelial cells (AEC) have been implicated in asthma causation. 9 The AEC provides a physical barrier against penetration of environmental exposures into the respiratory tissues, and this cell layer is now understood to be an important component of the innate immune system. Furthermore, AEC function is known to be different in children and adults with asthma compared to their non-asthmatic peers. [10] [11] [12] [13] Although it is known that AEC abnormalities are present in asthma, the fundamental question as to whether this is present at birth, that is, preceding the development of asthma and wheezing illness, remains unanswered.
We have collected nasal AEC within 48 h of birth in a cohort 14 and have followed up participants after 4 years. Nasal cells were sampled due to the difficult practical and ethical issues of sampling bronchial AEC in healthy neonates, and five studies described in a recent review 10 have demonstrated similarities between nasal and bronchial AEC in a number of different settings. The aim of this study was to determine whether altered neonatal AEC proinflammatory responses constitute risk factors for later asthma symptoms. Wheeze in young children is often transient and does not progress to asthma, especially wheeze before the third birthday. 15 Here, we test the hypothesis that AEC function was abnormal at birth in those who have asthma symptoms at 4 years of age. Since asthma is associated with atopic conditions such as eczema, we also stratified AEC function by asthma symptoms and eczema at 4 years of age. Our primary AEC outcome was interleukin (IL)-8 (CXCL8), and this was chosen because the secretion of this pro-inflammatory cytokine is enhanced by treatment with factors such as interleukin (IL)-1β and tumor necrosis factor alpha (TNFα) or house dust mite (HDM) in both neonatal nasal AEC 16 and bronchial AEC in children. 17 2 | METHODS
| Study subjects
Recruitment took place at 10-12 weeks gestation, and details of parental asthma, smoking and socioeconomic status were collected.
Within 48 h of birth, nasal AEC were obtained by brushing and cultured in a submerged model. 16 In a subset of individuals, there were sufficient cells available for cultured AEC to also be exposed to lipopolysaccharide (LPS). Close to the child's fourth birthday a postal questionnaire was completed. A third party 18 with permissions to access the child's contact details through Scottish healthcare records forwarded to parents of the study participants a questionnaire containing all the respiratory module questions of the International Study of Asthma and Allergy in Children (ISAAC) and also the question from the ISAAC eczema module for 6-7 year olds "has your child ever had eczema?" 19 "Recent wheeze" was defined as wheeze in the last 12 months and was the primary outcome. "Never wheeze"
was defined as negative responses to both "ever wheeze" and "wheeze in the last 12 months" questions. Cytokine/chemokine concentrations (pg/mL) in the 0.5 mL overlay medium were normalised to AEC protein content and expressed as the pg/mg protein.
| Analysis
The Mann-Whitney test was used to describe the significance of differences in cytokines/chemokines between children with recent wheeze and without recent wheeze and also between those with recent wheeze and never wheeze. Where differences were seen between children with and without recent wheeze, cytokine/chemokine
concentrations were compared across groups stratified by recent wheeze and eczema and significance determined using the KruskalWallis test. Standard statistical software was used (IBM SPSS, version 23.0.0) and a P value of <0.05 was considered significant.
3 | RESULTS
| Study subjects
There were 269 mothers recruited, 192 neonates were sampled (many were taken home prior to sampling), and AEC cultured in 139 individuals of whom 120 were contacted and their questionnaires returned by 91. Table 2 , Figure 1 . Children with recent wheeze had reduced AEC release of IL-8/CXCL8 after stimulation with IL-1β and TNFα compared to those without recent wheeze (P < 0.001, Figure 1 ). Additionally, AEC release of IL-6 (0.013), GMCSF (P = 0.012), and ICAM-1 (P = 0.017) was reduced after stimulation with IL-1β and TNFα in those with recent wheeze compared to no recent wheeze ( Table 2 ). The release of IL-8/CXCL8 was also reduced in children with recent wheeze after treatment with LPS (P = 0.004) compared to those with no recent wheeze ( Table 2 ). The AEC ICAM-1 (P = 0.038, Table 2 ) and RANTES/CCL5 (P = 0.042, Table 2 wheeze and never wheeze (online supplement E- Table 6 ).
3.3 | Neonatal AEC cytokine/chemokine release across groups stratified by recent wheeze and reported eczema
There were 54 children with neither wheeze nor eczema, 26 with eczema no wheeze, five with wheeze no eczema, and six with both The units are pg/mg protein. *P < 0.001, **P = 0.013, ***P = 0.012, **** P = 0.017, ***** P = 0.004, ****** P = 0.038, and ******* P = 0.049.
FIGURE 1 Scatter plot comparing interleukin (IL)-8/CXCL8
release from neonatal nasal airway epithelial cells after 24 h exposure to either medium alone or medium plus IL-1β and tumor necrosis factor (TNF)-α for individuals with parentreported wheeze in the last 12 months at 4 years of age compared to no-wheeze controls. There is a substantial literature, summarised in two recent reviews, 10, 11 which demonstrates that in vitro AEC function is different in children with asthma compared to those without asthma but what has been uncertain is whether the AEC dysfunction is the cause or the consequence of asthma. Nasal AEC from children with wheeze released less IL-8/CXCL8, IL-6, and GMCSF compared to non-wheezing controls 20 and bronchial AEC from adults with asthma have evidence of reduced innate immune responses after exposure to rhinovirus. 12, 13 The findings of our study are consistent with these studies from children and adults and suggest that the differences precede the onset of symptoms.
There are some studies whose results are apparently inconsis- There are some considerations which should be given to these results. First, the sample size was relatively small with only eleven children having had recent wheeze. However, the highly significant and large difference in IL-8/CXCL8 release (our cytokine/chemokine of primary interest) after exposure to IL-1β and TNF-α between children with and without wheeze is unlikely to be a false positive finding, as is the consistent reduction in AEC release of several cytokines/chemokines in association with later wheeze. The response of the respiratory system to early infection is widely considered to be important to FIGURE 2 Scatter plot comparing interleukin (IL)-8/CXCL8 release from neonatal nasal airway epithelial cells after 24 h exposure to either medium alone or to medium plus IL-1β and tumor necrosis factor (TNF)-α for individuals stratified by parentreported wheeze in the last 12 months and history of eczema at 4 years of age compared with no-wheeze/no eczema controls. The P value is from the Kruskal-Wallis test. There was no significant difference across the groups exposed to medium alone. The horizontal lines indicate the mean IL-8/CXCL8 value the later development of asthma 25 and the inflammatory mediators associated with wheeze in this study are all recognized as being important to host airway response to infection: IL-8/ CXCL8 is a potent neutrophil chemo-attractant; IL-6 has both anti-and pro-inflammatory properties 26 ; and ICAM-1 is a ligand for LFA1 (a receptor found on leukocytes 27 ) and a receptor rhinovirus. 28 The analysis of AEC response after LPS exposure and where individuals were stratified by wheeze and eczema yielded very small groups with wheeze and these results should be treated with caution. Alternatively the group with eczema but not wheeze was adequate in size to infer that there was no substantial difference compared to the group with neither eczema nor wheeze. Our study is limited by not collecting measurements of atopy or lung function. An additional limitation of our study was that the cohort recruited included 25% of mothers with a history of asthma and 5% who smoked, whereas the corresponding proportions in the general population are 10%
and 20%, so these results may not be generalizable. A final limitation is that we used a submerged model and an air-liquid interface model could have been more appropriate since it contains differentiated cells. 10 In summary, these findings suggest that a congenital abnormality in AEC responses to stimuli predispose children to developing wheeze later in life. The progress from wheeze in 4 years old into diagnosed asthma in older children is not inevitable and we will follow-up this group of children to determine whether the associations between neonatal AEC responses and wheeze persist. In the meantime, these novel findings now require confirmation in larger and older populations.
